Browse by Title
Showing results 152201 to 152220 of 276142
| Phantom-node method for shell models with arbitrary cracks Chau-Dinh, Thanh; Zi, Goangseup; Lee, PhillSeung; Rabczuk, Timon; Song, Jeong-Hoon, COMPUTERS STRUCTURES, v.92-93, pp.242 - 256, 2012-02 |
| PhantomPen: virtualization of pen head for digital drawing free from pen occlusion & visual parallax Lee, David; Son, KyoungHee; Lee, Joon Hyub; Bae, Seok-Hyung, UIST 2012, pp.331 - 340, ACM, 2012-10-09 |
| PhaRaO: Direct Radar Odometry using Phase Correlation Park, Yeong Sang; Shin, Young-Sik; Kim, Ayoung, IEEE International Conference on Robotics and Automation, ICRA 2020, pp.2617 - 2623, Institute of Electrical and Electronics Engineers Inc., 2020-05-31 |
| Pharmaceutical composition for improving, preventing or treating muscle related disease comprising ginsenoside Rh2 Yi, Gwan-Su; Li, Yi; Lee, Yoon Hyeok |
| Pharmaceutical composition for inhalation administration for labeling pulmonary tumorous lesion, containing fluorescent contrast agent as active ingredient Park, Ji-Ho; Oh, Chanhee; Lim, Ji Young; Jung, Daeho; Kim, Hyun Koo; Quan, Yuhua; Choi, Byeong-Hyeon; et al |
| PHARMACEUTICAL COMPOSITION FOR SUPPRESSING APPETITE, CONTAINING N2-(M-TRIFLUOROBENZYL), N6-(P-NITROBENZYL)PURINE (TNP) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT Kim, Seyun; Kim, Min Seon; Kang, Gilmyoung |
| PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING RNA OLIGONUCLEOTIDE 최병석; 강석조; 이장현; 민지연; 전동민; 성시은 |
| Pharmaceutical composition for treating cuts Lee, Sang Yup; Yoo, Won Min; Kim, Soon Cheol; Chung, Hannah; Kim, Jiyong |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; LEE, Janghyun; MIN, Ji Youn; CHUN, Dongmin; SUNG, Si-Eun |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| Pharmaceutical composition for treatment of cancer comprising RNA oligonucleotide Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| Pharmaceutical Composition for Treatment of Wounds 이상엽; 유원민; 김순철; 정해나; 김지용 |
| Pharmaceutical Firms' Strategic Decisions and Patients' Welfare Dynamics Kim, Wonjoon; Paris, C; Dick, R, The Sixth Marketing Dynamics Conference, Stern School of Business, New York University, 2009-08-28 |
| Pharmaceutical Firms' Strategic Decisions and Patients' Welfare Dynamics: Innovate or Imitate? Kim, Wonjoon; Paris, C; Dick, R, American Economic Association Annual Meeting 2008, American Economic Association, 2008-01-05 |
| Pharmaceutical Firms' Strategic Innovation Decision Kim, Wonjoon; Paris, C; Dick, R, Korea Productivity Association Conference, Korea Productivity Association, 2011-02-11 |
| Pharmacogenetics for rheumatic diseases = 류마티스 질환의 약물유전학 연구link Kim, Eun-Jin; 김은진; et al, 한국과학기술원, 2010 |
Discover
Type
Open Access
Date issued
- 31,154 2020 - 2024
- 99,968 2010 - 2019
- 75,670 2000 - 2009
- 44,727 1990 - 1999
- 14,360 1980 - 1989
- 62 1964 - 1969